potassium;1-[3-[(E)-3-[4-(4-acetyl-2-methylphenyl)-3,6-dihydro-2H-pyridin-1-yl]-2-methylbut-1-enyl]-2-methyl-4-pyridinyl]-4-(methylamino)pyridin-2-one;butanamide;ethane;7-fluoro-1,4,4-trimethyl-6-[[3-methyl-4-(2-propylpentyl)piperazin-1-yl]methyl]-3H-2,1-benzoxazine;hydroxide

C62H93FKN8O5- — CID 177356423

IUPACpotassium;1-[3-[(E)-3-[4-(4-acetyl-2-methylphenyl)-3,6-dihydro-2H-pyridin-1-yl]-2-methylbut-1-enyl]-2-methyl-4-pyridinyl]-4-(methylamino)pyridin-2-one;butanamide;ethane;7-fluoro-1,4,4-trimethyl-6-[[3-methyl-4-(2-propylpentyl)piperazin-1-yl]methyl]-3H-2,1-benzoxazine;hydroxide
SMILESCC.CCCC(CCC)CN1CCN(Cc2cc3c(cc2F)N(C)OCC3(C)C)CC1C.CNc1ccn(-c2ccnc(C)c2/C=C(\C)C(C)N2CC=C(c3ccc(C(C)=O)cc3C)CC2)c(=O)c1.[CH2-]CCC(N)=O.[K+].[OH-]
InChIInChI=1S/C31H36N4O2.C25H42FN3O.C4H8NO.C2H6.K.H2O/c1-20(18-29-22(3)33-13-9-30(29)35-16-12-27(32-6)19-31(35)37)23(4)34-14-10-25(11-15-34)28-8-7-26(24(5)36)17-21(28)2;1-7-9-20(10-8-2)16-29-12-11-28(15-19(29)3)17-21-13-22-24(14-23(21)26)27(6)30-18-25(22,4)5;1-2-3-4(5)6;1-2;;/h7-10,12-13,16-19,23,32H,11,14-15H2,1-6H3;13-14,19-20H,7-12,15-18H2,1-6H3;1-3H2,(H2,5,6);1-2H3;;1H2/q;;-1;;+1;/p-1/b20-18+;;;;;
InChIKeyHMGUXZLQKZMZGL-HAPIHCSOSA-M
MW1088.57 g/mol
LogP8.82
Rot. Bonds17

About potassium;1-[3-[(E)-3-[4-(4-acetyl-2-methylphenyl)-3,6-dihydro-2H-pyridin-1-yl]-2-methylbut-1-enyl]-2-methyl-4-pyridinyl]-4-(methylamino)pyridin-2-one;butanamide;ethane;7-fluoro-1,4,4-trimethyl-6-[[3-methyl-4-(2-propylpentyl)piperazin-1-yl]methyl]-3H-2,1-benzoxazine;hydroxide

potassium;1-[3-[(E)-3-[4-(4-acetyl-2-methylphenyl)-3,6-dihydro-2H-pyridin-1-yl]-2-methylbut-1-enyl]-2-methyl-4-pyridinyl]-4-(methylamino)pyridin-2-one;butanamide;ethane;7-fluoro-1,4,4-trimethyl-6-[[3-methyl-4-(2-propylpentyl)piperazin-1-yl]methyl]-3H-2,1-benzoxazine;hydroxide (PubChem CID 177356423) has the molecular formula C62H93FKN8O5- and a molecular weight of 1088.57 g/mol. Its IUPAC name is potassium;1-[3-[(E)-3-[4-(4-acetyl-2-methylphenyl)-3,6-dihydro-2H-pyridin-1-yl]-2-methylbut-1-enyl]-2-methyl-4-pyridinyl]-4-(methylamino)pyridin-2-one;butanamide;ethane;7-fluoro-1,4,4-trimethyl-6-[[3-methyl-4-(2-propylpentyl)piperazin-1-yl]methyl]-3H-2,1-benzoxazine;hydroxide.

Molecular Properties

Compound Namepotassium;1-[3-[(E)-3-[4-(4-acetyl-2-methylphenyl)-3,6-dihydro-2H-pyridin-1-yl]-2-methylbut-1-enyl]-2-methyl-4-pyridinyl]-4-(methylamino)pyridin-2-one;butanamide;ethane;7-fluoro-1,4,4-trimethyl-6-[[3-methyl-4-(2-propylpentyl)piperazin-1-yl]methyl]-3H-2,1-benzoxazine;hydroxide
PubChem CID177356423
Molecular FormulaC62H93FKN8O5-
Molecular Weight1088.57 g/mol
Exact Mass1087.69
IUPAC Namepotassium;1-[3-[(E)-3-[4-(4-acetyl-2-methylphenyl)-3,6-dihydro-2H-pyridin-1-yl]-2-methylbut-1-enyl]-2-methyl-4-pyridinyl]-4-(methylamino)pyridin-2-one;butanamide;ethane;7-fluoro-1,4,4-trimethyl-6-[[3-methyl-4-(2-propylpentyl)piperazin-1-yl]methyl]-3H-2,1-benzoxazine;hydroxide
SMILESCC.CCCC(CCC)CN1CCN(Cc2cc3c(cc2F)N(C)OCC3(C)C)CC1C.CNc1ccn(-c2ccnc(C)c2/C=C(\C)C(C)N2CC=C(c3ccc(C(C)=O)cc3C)CC2)c(=O)c1.[CH2-]CCC(N)=O.[K+].[OH-]
InChIInChI=1S/C31H36N4O2.C25H42FN3O.C4H8NO.C2H6.K.H2O/c1-20(18-29-22(3)33-13-9-30(29)35-16-12-27(32-6)19-31(35)37)23(4)34-14-10-25(11-15-34)28-8-7-26(24(5)36)17-21(28)2;1-7-9-20(10-8-2)16-29-12-11-28(15-19(29)3)17-21-13-22-24(14-23(21)26)27(6)30-18-25(22,4)5;1-2-3-4(5)6;1-2;;/h7-10,12-13,16-19,23,32H,11,14-15H2,1-6H3;13-14,19-20H,7-12,15-18H2,1-6H3;1-3H2,(H2,5,6);1-2H3;;1H2/q;;-1;;+1;/p-1/b20-18+;;;;;
InChIKeyHMGUXZLQKZMZGL-HAPIHCSOSA-M
XLogP8.82
TPSA159.27 Ų
H-Bond Donors2
H-Bond Acceptors12
Rotatable Bonds17
Heavy Atoms77
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001088.57
LogP ≤ 58.82
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1012

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}

Analyze potassium;1-[3-[(E)-3-[4-(4-acetyl-2-methylphenyl)-3,6-dihydro-2H-pyridin-1-yl]-2-methylbut-1-enyl]-2-methyl-4-pyridinyl]-4-(methylamino)pyridin-2-one;butanamide;ethane;7-fluoro-1,4,4-trimethyl-6-[[3-methyl-4-(2-propylpentyl)piperazin-1-yl]methyl]-3H-2,1-benzoxazine;hydroxide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of potassium;1-[3-[(E)-3-[4-(4-acetyl-2-methylphenyl)-3,6-dihydro-2H-pyridin-1-yl]-2-methylbut-1-enyl]-2-methyl-4-pyridinyl]-4-(methylamino)pyridin-2-one;butanamide;ethane;7-fluoro-1,4,4-trimethyl-6-[[3-methyl-4-(2-propylpentyl)piperazin-1-yl]methyl]-3H-2,1-benzoxazine;hydroxide?
The IUPAC name of potassium;1-[3-[(E)-3-[4-(4-acetyl-2-methylphenyl)-3,6-dihydro-2H-pyridin-1-yl]-2-methylbut-1-enyl]-2-methyl-4-pyridinyl]-4-(methylamino)pyridin-2-one;butanamide;ethane;7-fluoro-1,4,4-trimethyl-6-[[3-methyl-4-(2-propylpentyl)piperazin-1-yl]methyl]-3H-2,1-benzoxazine;hydroxide (CID 177356423) is potassium;1-[3-[(E)-3-[4-(4-acetyl-2-methylphenyl)-3,6-dihydro-2H-pyridin-1-yl]-2-methylbut-1-enyl]-2-methyl-4-pyridinyl]-4-(methylamino)pyridin-2-one;butanamide;ethane;7-fluoro-1,4,4-trimethyl-6-[[3-methyl-4-(2-propylpentyl)piperazin-1-yl]methyl]-3H-2,1-benzoxazine;hydroxide.
What is the SMILES notation for potassium;1-[3-[(E)-3-[4-(4-acetyl-2-methylphenyl)-3,6-dihydro-2H-pyridin-1-yl]-2-methylbut-1-enyl]-2-methyl-4-pyridinyl]-4-(methylamino)pyridin-2-one;butanamide;ethane;7-fluoro-1,4,4-trimethyl-6-[[3-methyl-4-(2-propylpentyl)piperazin-1-yl]methyl]-3H-2,1-benzoxazine;hydroxide?
The canonical SMILES for potassium;1-[3-[(E)-3-[4-(4-acetyl-2-methylphenyl)-3,6-dihydro-2H-pyridin-1-yl]-2-methylbut-1-enyl]-2-methyl-4-pyridinyl]-4-(methylamino)pyridin-2-one;butanamide;ethane;7-fluoro-1,4,4-trimethyl-6-[[3-methyl-4-(2-propylpentyl)piperazin-1-yl]methyl]-3H-2,1-benzoxazine;hydroxide is CC.CCCC(CCC)CN1CCN(Cc2cc3c(cc2F)N(C)OCC3(C)C)CC1C.CNc1ccn(-c2ccnc(C)c2/C=C(\C)C(C)N2CC=C(c3ccc(C(C)=O)cc3C)CC2)c(=O)c1.[CH2-]CCC(N)=O.[K+].[OH-].
What is the InChIKey of potassium;1-[3-[(E)-3-[4-(4-acetyl-2-methylphenyl)-3,6-dihydro-2H-pyridin-1-yl]-2-methylbut-1-enyl]-2-methyl-4-pyridinyl]-4-(methylamino)pyridin-2-one;butanamide;ethane;7-fluoro-1,4,4-trimethyl-6-[[3-methyl-4-(2-propylpentyl)piperazin-1-yl]methyl]-3H-2,1-benzoxazine;hydroxide?
The InChIKey is HMGUXZLQKZMZGL-HAPIHCSOSA-M. The full InChI is InChI=1S/C31H36N4O2.C25H42FN3O.C4H8NO.C2H6.K.H2O/c1-20(18-29-22(3)33-13-9-30(29)35-16-12-27(32-6)19-31(35)37)23(4)34-14-10-25(11-15-34)28-8-7-26(24(5)36)17-21(28)2;1-7-9-20(10-8-2)16-29-12-11-28(15-19(29)3)17-21-13-22-24(14-23(21)26)27(6)30-18-25(22,4)5;1-2-3-4(5)6;1-2;;/h7-10,12-13,16-19,23,32H,11,14-15H2,1-6H3;13-14,19-20H,7-12,15-18H2,1-6H3;1-3H2,(H2,5,6);1-2H3;;1H2/q;;-1;;+1;/p-1/b20-18+;;;;;.
What are the key properties of potassium;1-[3-[(E)-3-[4-(4-acetyl-2-methylphenyl)-3,6-dihydro-2H-pyridin-1-yl]-2-methylbut-1-enyl]-2-methyl-4-pyridinyl]-4-(methylamino)pyridin-2-one;butanamide;ethane;7-fluoro-1,4,4-trimethyl-6-[[3-methyl-4-(2-propylpentyl)piperazin-1-yl]methyl]-3H-2,1-benzoxazine;hydroxide?
potassium;1-[3-[(E)-3-[4-(4-acetyl-2-methylphenyl)-3,6-dihydro-2H-pyridin-1-yl]-2-methylbut-1-enyl]-2-methyl-4-pyridinyl]-4-(methylamino)pyridin-2-one;butanamide;ethane;7-fluoro-1,4,4-trimethyl-6-[[3-methyl-4-(2-propylpentyl)piperazin-1-yl]methyl]-3H-2,1-benzoxazine;hydroxide has a molecular weight of 1088.57 g/mol, XLogP of 8.82, 17 rotatable bonds, 2 hydrogen bond donors, and 12 hydrogen bond acceptors.
Where does this data come from?
All data for potassium;1-[3-[(E)-3-[4-(4-acetyl-2-methylphenyl)-3,6-dihydro-2H-pyridin-1-yl]-2-methylbut-1-enyl]-2-methyl-4-pyridinyl]-4-(methylamino)pyridin-2-one;butanamide;ethane;7-fluoro-1,4,4-trimethyl-6-[[3-methyl-4-(2-propylpentyl)piperazin-1-yl]methyl]-3H-2,1-benzoxazine;hydroxide is sourced from PubChem (CID 177356423), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).